SoCalBio Mast
SoCalBio Weekly Update
Thanks to SoCalBio Weekly Update Sponsor

Past Weekly Updates

Partnership


SoCalBio Partners With FedEx to Offer up to 35% Discounts on Shipping Services to SoCalBio Members Through the BioBusiness Solutions Program... Learn more  

 

Featured SoCalBio Service Provider


Contact:

John Clapham, CEO

(909) 784-3350

 jclapham@biotech.com


The Pomona, CA-based PSC Biotech offers IT solutions and provides validation, quality and compliance software and services for life-science companies ...

learn more

Join SoCalBio
Recommended Events


September 7 - 9

Boston, MA

September 26- 28
Washington DC  

 


October 3-5
Pasadena, CA

Join SoCalBio
Join SoCalBio leaders to promote the biotech and device industries in the Greater Los Angeles Metro Area for job creation and overall economic growth.
 
When you join, you will enjoy significant discounts on products and services from lab and office supplies to insurance and scientific publications. Discounts are exclusive to SoCalBio member companies in Los Angeles, Orange, Ventura, Santa Barbara, Riverside and  San Bernardino counties... Click here to see why
Become a Member
Thanks to SoCalBio Media Partners
May 9, 2011


Editor: Ahmed Enany
President & CEO
Southern California
Biomedical Council
enany@socalbio.org

www.socalbio.org
RSVP Now

Annual SoCalBio Workshop on  

Accessing Government Funding for Research

 

May 26, 2011 -- 7:30 am - 4:00 pm

(Calit2 Auditorium at the University of California Irvine)   

 


Doing Business Abroad

Learn about Market Growth Opportunities in Thailand

Tuesday, May 24, 2011 from 7:30am to 10:00 am

Wilshire Grand, Los Angeles, CA

SoCalBio encourages you to attend a complimentary executive breakfast seminar on Thailand: Growth Opportunities. This seminar will be hosted by Ms. Ajarin Pattanapanchai, Senior Executive Investment Advisor, who for many years, has been instrumental in formulating investment promotion policy and involved in various high profile US investment developments in Thailand. 

Ms Pattanapanchai will present the progressive investment policies, tax incentives, and other business services the Thai Government currently offers US companies. The industry focus will be on the biotech and medical devices sectors, with additional insights on opportunities in the alternative energy, electronics, software, and aerospace sectors. In addition, an expert from these sectors is planning on giving an update on the current developments and support programs available to US companies. 

To RSVP, please contact Amanda Augustine at (202) 296-3795 or aaugustine@awscorp.com.
Opinion

Medical Devices: Lost in Regulation

Former Medtronic executive Paul Citron contends that the US leadership in the medical device field is being eroded by an excessively risk-averse and bureaucratic regulatory environment ...  Read article in Issues in Science and Technology, Spring 2011 
Incontinence

Caldera Medical Achieves CE Mark for Incontinence Implant

The Agoura Hills-based Caldera Medical announced that it has achieved CE Mark certification for its Desara Mini implant, an extension of its popular Desara brand for the treatment of Stress Urinary Incontinence. Desara Mini combines the proven Desara mesh with a secure fixation system that allows for sling placement with a single incision ... Read more
Sudden Cardiac Arrest

Cameron Health Completes Enrollment in Pivotal FDA Clinical Study of its S-ICD Cardiac Implant

The San Clemente-based Cameron Health plans to submit data from this pivotal study to the FDA in late 2011 requesting marketing approval for the S-ICD System in the United States. The S-ICD System received CE mark in Europe in 2009 based on data recently published in the July 2010 issue of the New England Journal of Medicine. Approximately 800 patients have been implanted with the S-ICD System worldwide ... Read more
Partnership

Allergan and Molecular Partners Enter into an Exclusive License Agreement For MP0112 For the Treatment of Retinal Diseases

Under the agreement, Allergan obtains exclusive global rights for MP0112 for ophthalmic indications. The parties will work together during phase IIb development and, Allergan will be responsible for phase III development and commercialization activities. Molecular Partners will receive an up-front payment of USD $45 million and is further entitled to receive additional payments of up to an aggregate of USD $375 million upon meeting certain development, regulatory and sales milestones. In addition, Molecular Partners will receive tiered double-digit royalties on any future sales of MP0112 ... Read more
Financing

Response Genetics, Inc. Announces $2.3 Million Equity Financing

The Los Angeles-based molecular diagnostics company intends to use the net proceeds of this offering for payment of the expenses and costs associated with its operations and for other general corporate purposes ... Read more
 
Jobs Available

Gilead (San Dimas)

About SoCalBio 
 
SoCalBio membership links you to partners, contract manufacturers, regulatory and legal experts, and policy makers. The organization's programs help emerging biotech and medical device companies grow. Membership is affordable -- as low as $500 -- and offers access to networking opportunities, advocacy, discounts through our group purchasing program group purchasing program and other benefits you simply can't find elsewhere ... Join SoCalBio